SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Linda Kaplan who wrote (5439)9/2/1998 10:37:00 PM
From: Brander  Read Replies (1) | Respond to of 7041
 
The company, in the case ZONA, has to be notified of the decision to reject or accept the NDA within 60 days. ZONA should know by the 11th, or by the 14th by the latest. ZONA will probably be informed prior to the deadline, and I would not be surprised it they already know what the decision is. After that, assuming the FDA accepts their NDA, the final decision will be announced in six months to one year.
I doubt the stock price will remain flat during that time. I expect up and down fluctuations, and plenty of opportunities for short term traders.

B



To: Linda Kaplan who wrote (5439)9/3/1998 6:06:00 AM
From: biodoc  Read Replies (2) | Respond to of 7041
 
No, I think they would send it by an overnight means. My own personal decision is whether to cash in at a nice, but not obscene, profit on my Sept 17.5 puts now, or wait for nearer to expiration. I am concerned that if the application is accepted, there would be a small bump to over 16. I've also got longer term puts so the game isn't dead if I sell the short term ones.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News